Please login to the form below

atrial fibrillation

This page shows the latest atrial fibrillation news and features for those working in and with pharma, biotech and healthcare.

BMS builds case for cardiovascular drug mavacamten with new analysis

In both obstructive or non-obstructive HCM patients, physical exertion can cause fatigue or shortness of breath, and has also been associated with increased risks of atrial fibrillation, stroke, heart failure

Latest news

FDA accepts BMS’ investigational cardiovascular drug mavacamten for review

In both obstructive or non-obstructive HCM patients, physical exertion can cause fatigue or shortness of breath, and has also been associated with increased risks of atrial fibrillation, stroke, heart failure
FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

The FDA has approved Micro Labs and Mylan’s generics to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF), one of Eliquis’ key indications.
Correvio crumbles as FDA panel rejects AFib drug

drug for atrial fibrillation, citing safety concerns. ... The treatment landscape is currently missing a rapid, efficacious and well tolerated option to treat patients with recent onset atrial fibrillation and we believe Brinavess has the potential to
Regeneron reveals first data for bispecific antibody in multiple myeloma

Five patients experienced grade 3 or higher treatment-emergent adverse events, including lymphopenia, hypertension, anaemia, atrial fibrillation fatigue, febrile neutropenia, pain in extremity, septic shock and thrombocytopenia.
Apple Watch shows promise in heart study, but doctors sceptical

a role in detecting conditions such as atrial fibrillation, a deadly and often undiagnosed disease. ... partnered with pharma giant Johnson and Johnson to assess the impact of wearable technology on earlier detection of atrial fibrillation.

More from news
Approximately 10 fully matching, plus 118 partially matching documents found.

Latest Intelligence

Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?

When Novel Oral Anticoagulants (NOACs) entered the market some years ago for the prevention of stroke in atrial fibrillation, the potential for market disruption was clear.
Digital disruption in market access

Accession is currently working with the NHS in the UK to prevent the devastating impact of stroke caused by atrial fibrillation (AF) through the use of digital technology.
Is it possible to change behaviour virtually?

Clinicians' ability to identify the correct patients for different stroke prevention treatments had been identified as a barrier to optimal management of non-valvular atrial fibrillation (NVAF).
Deal Watch table for October 2013

XEN-D103 ion channel modulator for atrial fibrillation (phase I). 162.4. Anacor / Valeant.
Interview: Allan Hillgrove, Boehringer

American College of Cardiology (ACC) to educate cardiologists in China about stroke prevention in atrial fibrillation (AF) – a condition for which Boehringer markets Pradaxa (dabigatran).

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

Daniel Beach moves from Ketchum to Portland Health

Prior to this, Beach held director-level roles at DBHC Consulting, the Atrial Fibrillation Association, and Just:: Health Communications.
Merck & Co’s Jürgen Polifka joins Cardiome

Will lead commercialisation in Europe of atrial fibrillation treatment Brinavess. Jürgen Polifka has left his role at Merck and Co to join Canada-based biopharma Cardiome as general manager, sales and ... Polifka was most recently regional marketing

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

The Week After

The Week After looks at the risks associated with atrial fibrillation - the teaser looks to capture the attention of cardiology to step in and act.
What is changing in cardiovascular disease care?

Improving the detection and management of high-risk conditions, such as high blood pressure, high cholesterol and Atrial Fibrillation (AF) that can cause CVD, as well as many cases of dementia,
Artificial Intelligence in healthcare

enough for you, the National Institute for Health and Care Excellence (NICE) has approved the use of ‘AliveCor’, which is a mobile heart monitor that can detect, monitor, and manage atrial ... fibrillation – a potentially fatal irregular heart
Apple Watch Series 4: A life-saving tool or just making us more health obsessed?

Taking an electrocardiogram with your watch:. Take atrial fibrillation for example – a heart condition that causes an irregular and often abnormally fast heart rate, leaving the individual at increased risk of ... 3. For those individuals who display
NOAC Education: Empowering Stroke Prevention

The use of oral anticoagulants in patients with atrial fibrillation. NOAC reversal agents.

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Senior Consultant, Pricing & Market Access Consultancy, circ...: circa £100K package

Digital Project Director, Healthcare Marketing Agency patient fo...: Highly competitive salary

Digital account director: Competitive

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

Group Account Director, Patient focussed account, Healthcare com...: circa £90K

Digital Engagement Strategist, Healthcare Brand Communications, ...: £75-90K

Events Executive: Depending on Experience

Project Director, Healthcare Marketing Agency patient focus Lond...: Highly competitive salary

Account Manager - Healthcare Consultancy: Salary depending on experience

PMHub

Add my company

Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Guide: How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand: The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started: Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...

Email:
Password:

Please login to the form below

atrial fibrillation

COVID-19 Updates and Daily News

Featured jobs

Quick links